• Research
  • Capacity Building
  • Policy and Advocacy
  • Resource Centre

Publications

testing paper web

Hepatitis B and C testing: Why? Who? How?

A guidance paper on testing in community and harm reduction settings

This paper aims to stimulate services to engage in HCV and HBV awareness raising and in particular to inform community members, social and health care practitioners about current HBV/HCV testing and diagnosis methods, screening technologies and other aspects around the issue.

 
cover peer-training-manual

Act Now! Liver or die

A PEER TRAINING MANUAL
streep tussen2
Monitoring of the testing for hepatitis C has been implemented in low-threshold services in Germany, Romania, Portugal and Finland.

The monitoring aimed at collecting data on the proportion of drug users who have been tested for HCV, the prevalence of HCV and the number of drug users that should be tested for hepatitis C.
streep tussen2
hcv client survey report In the four European countries Finland, Germany, Romania and Portugal a broaderinvestigation on drug use and infections with the hepatitis C virus (HCV) was conducted.

One part of the research consisted in the longitudinal screening of visitors of low-threshold drug services for previous HCV antibody testing and their current HCV testing need. A second part consisted in a survey aimed at exploring the drug users’ experiences with testing and treatment.

 
streep tussen2
hepatitis treatment en care Hepatitis C:
Treatment and care for people who inject drugs
streep tussen2
  

 

  BMC Infectious Diseases

 

Publication of the BMC Infectious Desease
Journal Supplement 'Viral Hepatitis and Drug Use in Europe´.

The publication was produced in the framework of the 'Hepatitis C Initiative' project by CHIP, The Centre for Health and Infectious Disease Research, University of Copenhagen.

The publication contains five research articles and a discussion article that collectively demonstrate the potential for smart research to help transform the political and public health response to hepatitis C in Europe and presents no less than ten commentaries about crucial issues in this realm with a broad diversity of experiences represented in the contributions.
 
The full content of the supplement can be found at http://www.biomedcentral.com/bmcinfectdis/supplements/14/S6.
The link to the supplement is permanently accessible via the Supplements link on the Article page of the journal website
streep tussen2